Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Other Working Capital Changes: 2016-2024

Historic Other Working Capital Changes for Arcus Biosciences (RCUS) over the last 9 years, with Dec 2024 value amounting to -$56.0 million.

  • Arcus Biosciences' Other Working Capital Changes fell 138.81% to -$26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$256.0 million, marking a year-over-year decrease of 725.81%. This contributed to the annual value of -$56.0 million for FY2024, which is 17.65% up from last year.
  • According to the latest figures from FY2024, Arcus Biosciences' Other Working Capital Changes is -$56.0 million, which was up 17.65% from -$68.0 million recorded in FY2023.
  • Over the past 5 years, Arcus Biosciences' Other Working Capital Changes peaked at $188.0 million during FY2020, and registered a low of -$368.0 million during FY2021.
  • In the last 3 years, Arcus Biosciences' Other Working Capital Changes had a median value of -$68.0 million in 2023 and averaged -$78.7 million.
  • As far as peak fluctuations go, Arcus Biosciences' Other Working Capital Changes soared by 9,500.00% in 2020, and later tumbled by 295.74% in 2021.
  • Arcus Biosciences' Other Working Capital Changes (Yearly) stood at $188.0 million in 2020, then plummeted by 295.74% to -$368.0 million in 2021, then skyrocketed by 69.57% to -$112.0 million in 2022, then spiked by 39.29% to -$68.0 million in 2023, then increased by 17.65% to -$56.0 million in 2024.